Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Human on Chip : Microsensor unit and control algorithm integration for brain on a chip drug testing applications and development

Objetivo

"Cherry Biotech is an innovative French company which develops and commercializes microfluidic instruments for life sciences and healthcare. We position ourselves on a biological research market in which we are developing a range of tools dedicated to high resolution imaging. Other cellular environment control systems are also in test or development to support business growth. This technical base and the transversal skills held by the team has ideally positioned Cherry Biotech to carry out ambitious projects in the growing market of the Organs on a chip.
The design, development and implementation of microfluidic devices called ""Organ-on-a-Chip"" require the understanding and the integration of numerous components (technical, biological issues and constraints ...).
The candidate will take over from its genesis to the development of proof of concept the development of a microfluidic instrumentation platform to test therapeutic molecules on artificial organs (Brain) integrated within microfluidic chips. His challenge will be to integrate a complex technical environment (instrumentation, sensors, microfluidics) with important biological constraints.
"

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

CSA - Coordination and support action

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) H2020-INNOSUP-2016-2017

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

CHERRY BIOTECH
Aportación neta de la UEn
€ 81 875,00
Dirección
2EME ETAGE, HALLS A-B ET C14 RUE DE LA BEAUNE
93100 Montreuil
Francia
Pyme
Sí
Región
Pays de la Loire Pays de la Loire Vendée
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 81 875,00